
Multiple sclerosis is a demyelinating chronic neurologic disease that can lead to disability and thus to deterioration of quality of life. Psychological parameters such as ego defense mechanisms, defense styles and family environment are important factors in the adaptation process, and as such they can play important roles in QoL. This study aims to assess the psychological factors as well as the clinical and demographic characteristics related to mental health quality of life (MHQoL).
This was an observational, cross-sectional study conducted in a sample of 90 people with MS in the years 2018–2020. All participants completed the following questionnaires: MSQoL-54, DSQ-88, LSI, FES-R, SOC, BDI-II, STAI. Disability was assessed using EDSS.
In multiple linear regression, significant roles were played by depression (R2: 41.1%, p: 0.001) and, to a lesser extent, the event of a relapse (R2: 3.5%, p: 0.005), expressiveness (R2: 3.6%, p < 0.05) and image distortion style (R2: 4.5%, p: 0.032). After performing a hierarchical-stepwise analysis (excluding depression), the important factors were maladaptive defense style (R2: 23.7%, p: 0.002), the event of relapse (R2: 8.1%, p < 0.001), expressiveness (R2: 5.5%, p: 0.004) and self-sacrificing defense style (R2: 2.4%, p: 0.071).
Psychological factors play important roles in MHQoL of people with multiple sclerosis. Thus, neurologists should integrate in their practice an assessment by mental health specialists. Moreover, targeted psychotherapeutic interventions could be planned i to improve QoL.
Citation: Anthi Amaslidou, Ioanna Ierodiakonou-Benou, Christos Bakirtzis, Ioannis Nikolaidis, Theano Tatsi, Nikolaos Grigoriadis, Ioannis Nimatoudis. Multiple sclerosis and mental health related quality of life: The role of defense mechanisms, defense styles and family environment[J]. AIMS Neuroscience, 2023, 10(4): 354-375. doi: 10.3934/Neuroscience.2023027
[1] | Wenjun Xia, Jinzhi Lei . Formulation of the protein synthesis rate with sequence information. Mathematical Biosciences and Engineering, 2018, 15(2): 507-522. doi: 10.3934/mbe.2018023 |
[2] | Jacques Demongeot, Jules Waku, Olivier Cohen . Combinatorial and frequency properties of the ribosome ancestors. Mathematical Biosciences and Engineering, 2024, 21(1): 884-902. doi: 10.3934/mbe.2024037 |
[3] | Robert P. Gilbert, Philippe Guyenne, Ying Liu . Modeling of the kinetics of vitamin D3 in osteoblastic cells. Mathematical Biosciences and Engineering, 2013, 10(2): 319-344. doi: 10.3934/mbe.2013.10.319 |
[4] | Mohamad Al Bannoud, Tiago Dias Martins, Silmara Aparecida de Lima Montalvão, Joyce Maria Annichino-Bizzacchi, Rubens Maciel Filho, Maria Regina Wolf Maciel . Integrating biomarkers for hemostatic disorders into computational models of blood clot formation: A systematic review. Mathematical Biosciences and Engineering, 2024, 21(12): 7707-7739. doi: 10.3934/mbe.2024339 |
[5] | Carsten Conradi, Elisenda Feliu, Maya Mincheva . On the existence of Hopf bifurcations in the sequential and distributive double phosphorylation cycle. Mathematical Biosciences and Engineering, 2020, 17(1): 494-513. doi: 10.3934/mbe.2020027 |
[6] | Wenhao Chen, Guo Lin, Shuxia Pan . Propagation dynamics in an SIRS model with general incidence functions. Mathematical Biosciences and Engineering, 2023, 20(4): 6751-6775. doi: 10.3934/mbe.2023291 |
[7] | Gerasimos G. Rigatos, Efthymia G. Rigatou, Jean Daniel Djida . Change detection in the dynamics of an intracellular protein synthesis model using nonlinear Kalman filtering. Mathematical Biosciences and Engineering, 2015, 12(5): 1017-1035. doi: 10.3934/mbe.2015.12.1017 |
[8] | S. Hossein Hosseini, Marc R. Roussel . Analytic delay distributions for a family of gene transcription models. Mathematical Biosciences and Engineering, 2024, 21(6): 6225-6262. doi: 10.3934/mbe.2024273 |
[9] | Wang-Ren Qiu, Qian-Kun Wang, Meng-Yue Guan, Jian-Hua Jia, Xuan Xiao . Predicting S-nitrosylation proteins and sites by fusing multiple features. Mathematical Biosciences and Engineering, 2021, 18(6): 9132-9147. doi: 10.3934/mbe.2021450 |
[10] | Siddhartha Kundu . Mathematical model of a short translatable G-quadruplex and an assessment of its relevance to misfolding-induced proteostasis. Mathematical Biosciences and Engineering, 2020, 17(3): 2470-2493. doi: 10.3934/mbe.2020135 |
Multiple sclerosis is a demyelinating chronic neurologic disease that can lead to disability and thus to deterioration of quality of life. Psychological parameters such as ego defense mechanisms, defense styles and family environment are important factors in the adaptation process, and as such they can play important roles in QoL. This study aims to assess the psychological factors as well as the clinical and demographic characteristics related to mental health quality of life (MHQoL).
This was an observational, cross-sectional study conducted in a sample of 90 people with MS in the years 2018–2020. All participants completed the following questionnaires: MSQoL-54, DSQ-88, LSI, FES-R, SOC, BDI-II, STAI. Disability was assessed using EDSS.
In multiple linear regression, significant roles were played by depression (R2: 41.1%, p: 0.001) and, to a lesser extent, the event of a relapse (R2: 3.5%, p: 0.005), expressiveness (R2: 3.6%, p < 0.05) and image distortion style (R2: 4.5%, p: 0.032). After performing a hierarchical-stepwise analysis (excluding depression), the important factors were maladaptive defense style (R2: 23.7%, p: 0.002), the event of relapse (R2: 8.1%, p < 0.001), expressiveness (R2: 5.5%, p: 0.004) and self-sacrificing defense style (R2: 2.4%, p: 0.071).
Psychological factors play important roles in MHQoL of people with multiple sclerosis. Thus, neurologists should integrate in their practice an assessment by mental health specialists. Moreover, targeted psychotherapeutic interventions could be planned i to improve QoL.
multiple sclerosis;
quality of life;
people with MS;
mental health related quality of life;
physical health related quality of life.
Production of proteins is one of most fundamental cellular processes, taking up to 75% of cellular resources in terms of chemical energy, in simple microbes [1]. The transcription-translation process description, mentioning only the most basic "elementary" processes, consists in:
1. production of mRNA molecules (including splicing),
2. initiation of these molecules with help of initiation factors (e.g., the initiation can include the circularization step though it is not universally required),
3. initiation of translation, recruiting the small ribosomal subunit,
4. assembly of full ribosomes,
5. elongation, i.e. movement of ribosomes along mRNA with production of protein,
6. termination of translation,
7. degradation of mRNA molecules,
8. degradation of proteins
Despite quite "linear" description of this process, a difficulty in the kinetic modeling of it arises when one tries to take into account the phenomenon of polysome [2,3], when several ribosomes are synthesizing peptides on a single mRNA at the same time. This leads to multiplicity of possible states of mRNA with various ribosome numbers and potentially different dynamics, interaction between ribosomes and other complex phenomena. This difficulty was evident already in the first published mathematical models of protein synthesis [4,5,6].
The process of protein synthesis and translation is a subject of mathematical modeling since long time ago starting from detailed kinetic models [4,5,7], taking into account stochastic aspects of translation [8] and using computer simulations for the case of large polysomes [9]. A number of chemical kinetics-based models of protein synthesis have been developed and analyzed in the last four decades [10,11,12]. Beyond chemical kinetics, various modeling formalisms such as Totally Asymmetric Simple Exclusion Process (TASEP) [13,14,15], Probabilistic Boolean Networks (PBN) [16], Petri Nets and max-plus algebra [17] have been applied to model the detailed kinetics of protein synthesis or some of its stages [18].
In the context of specific questions and applications of mathematical modeling to translation, dealing with detailed kinetic description of translation might be not optimal, and simplified models of translation can become more suitable. Thus, few attempts have been made in order to simplify the detailed kinetic description of protein synthesis. For example, two simple kinetic models of translation were introduced before in [19] and analyzed in detail in [20]. However, they were introduced without strict derivation from the detailed translation kinetics and did not allow taking into account neither degradation of mRNA nor existence of polysomes. Ad hoc simplified models of protein synthesis have been exploited for addressing specific contexts of translation regulation [21,22,23]. Using simplified models allows more direct determination of the most important control parameters of protein translation regulation.
We share the point of view that "useful models are simple and extendable" [24]. Following this paradigm, one needs to create the simplest kinetic model of protein synthesis and suggest a way to complexify it if needed to address a particular observation. Despite very long history of the mathematical modeling of protein synthesis, to our knowledge, no basic and simple kinetic description of the process, directly and formally derived from its detailed representation, was suggested until so far. This is the gap we close in this study.
In the following we start with a (1) detailed mechanistic description of the translation process with explicit representation of every state of translated mRNA, followed by (2) deriving the simplest and basic kinetic model of coupled transcription, translation and degradation, and (3) extending the model in order to take into account various effects. In this paper, the extensions will describe the saturation of mRNA initiation rate and the regulation of translation by microRNA.
The basic model is constructed by (1) correct lumping of the detailed model states and by (2) separating the descriptions of ribosomal turnover and the translation initiation through introducing a variable representing the pool of translating ribosomes. The simplest model remains linear under assumption of that the local concentrations of ribosomal subunits or initiation factors remain constant or their values change relatively slowly. To avoid non-physiological properties (such as a possibility of infinite number of ribosomes per mRNA), we modify the model by introducing delays in the initiation of ribosome and the effects of ribosome interactions. In this form, the model becomes more realistic but non-linear in some extensions.
Let us introduce the following notations:
L – length of mRNA (in nucleotides);
lm– length occupied on mRNA by fully assembled ribosome (in nucleotides);
kt– rate constant of production of mRNA molecules;
kd– rate constant of degradation of mRNA molecules;
kr– speed of movement of translating ribosome along mRNA (nucleotise/sec);
IF – various initiation factors;
S40 – small ribosome component;
S60 – large ribosome component.
Further we will use squared brackets to denote the concentrations of the corresponding molecular species: for example, [S40] will denote the local concentration of S40 ribosomal subunits. For the amounts of the components we keep the same notations as for the components themselves. Thus, R is amount of amount of ribosomes and the total amount of mRNA molecules is MT.
The simplest assumption about the production and destruction of mRNA is that the degradation process does not depend on the state of mRNA. Under this assumption the total pool of mRNAs is produced at rate kt and destroyed with rate constant kd, i.e. its dynamics is simple and autonomous:
dMTdt=kt−kd×[MT]. |
It is worth to notice that the production rate kt is an extensive quantity (it scales with the total volume of the system) whereas all rate constants are intensive ones.
The total pool of mRNA molecules can be separated in sub-pools of mRNA molecules in different states:
R0– mRNA molecules in non-initiated state (not ready for translation)
R_0– mRNA molecules in initiated state (ready for translation, with 40S subunit sitting at the mRNA)
R1– mRNA molecules with one single ribosome assembled and moving along the mRNA
R_1– mRNA molecules with one ribosome assembled and initiated for new incoming ribosome
R2– mRNA molecules with two ribosomes assembled and moving along the mRNA
R_2– mRNA molecules with two ribosomes assembled and initiated for new incoming ribosome
….
Rnmax– mRNA molecules with nmax ribosomes assembled and moving along the mRNA
R_nmax– mRNA molecules with nmax ribosomes assembled and initiated for new incoming ribosome
The sum of all sub-pools of mRNA should be equal to MT:
MT=nmax∑i=0(Ri+R_i) |
The number nmax is defined as the maximum number of ribosomes able to sit on mRNA: it may be roughly evaluated as
nmax=L/lm. | (2.1) |
Schematically, the process of translation can be represented as in Figure 1.
The time of passage of one ribosome along mRNA may be evaluated as
tp=L/kr, | (2.2) |
hence, the reaction rate constant of protein production and subsequent release of ribosomes from mRNA (shown in Figure 1 by backward arrows) may be evaluated as:
k3=kr/L. | (2.3) |
The transformation of states is described by the following chemical equations:
Ri→R_i (with rate constant k1), i=0…nmax
R_i→ Ri+1(with rate constant k2), i=0…nmax-1
Ri→ Ri−1 (with rate constant k3), i=1…nmax
R_i→R_i−1 (with rate constant k3), i=1…nmax
Ri→ Ri−1 (with rate constant krd), i=1…nmax
R_i→R_i−1 (with rate constant krd), i=1…nmax
To avoid using 2 × (nmax+1) states (which potentially can be large) to represent translation, we lump the description of the detailed process in the following way. We denote
M – amount of mRNA with translation initiation site not occupied by assembling ribosome,
F – amount of mRNA with translation initiation site occupied by assembling ribosome,
R – amount of ribosomes sitting on mRNA synthesizing proteins,
P – amount of proteins.
In terms of R_i and Ri variables, M and F represent the lumped values:
M=∑nmaxi=0Ri, F=∑nmaxi=0R_i and MT = M + F.
There are two lumped reactions and two reactions representing the turnover of ribosomes (as a result of translation termination and protein synthesis or spontaneous ribosome drop-off from mRNA without protein production):
M→F with reaction rate constant k1,
F→M +R with reaction rate constant k2,
R → null with reaction rate constant k3 .
R → null with reaction rate constant krd +k d (ribosome drop-off and degradation without protein production).
The reaction network describing transcription, translation and mRNA degradation is represented in Figure 2. We will denote this model as M0.
The corresponding list of equations is
{∙M=kt−kdM−k1M+k2F∙F=k1M−kdF−k2F∙R=k2F−k3R−krdR−kdR∙P=k3R−kpP | (2.4) |
which has the following solution for zero initial condition M(0) = F(0) = R(0) = P(0) = 0
M(t)=ktkdk2(k1+k2+kd)(1−e−kdt)+k1kd(1−e−(k1+k2+kd)t)(k1+k2+kd)(k1+k2), |
F(t)=ktkd1(k1+k2+kd)(k1+k2)[k1(k2+kd)−k1(k1+k2+kd)e−kdt+k1kde−(k1+k2+kd)t] |
R(t)=ktkdk1k2(k3+krd+kd)(k1+k2+kd)×[1−(k3+krd+kd)(k1+k2+kd)(k3+krd)(k1+k2)e−kdt+(k3+krd+kd)kd(k3+krd−k1−k2)(k1+k2)e−(k1+k2+kd)t+(k1+k2+kd)kd(k3+krd−k1−k2)(k3+krd)e−(k3+krd+kd)t], |
P(t)=ktkdk1k2k3kp(k1+k2+kd)(k3+krd+kd)[1−αde−kdt+α12e−(k1+k2+kd)t+α3e−(k3+krd+kd)t−αpe−kpt], | (2.5) |
αd=(k3+krd+kd)(k1+k2+kd)(k3+krd)(k1+k2)kpkp−kd,α12=(k3+krd+kd)kd(k3+krd−k1−k2)(k1+k2)kpkp−kd−k1−k2, |
α3=(k1+k2+kd)kd(k3+krd−k1−k2)(k3+krd)kpkp−kd−k3−krd,αP=1−αd+α3+α12 |
The simplest model M0 can be made more complex if some particular aspects of translation are needed to be represented in more details. Below we build several such modifications. In the model M0 we explicitly model the first round of mRNA initiation which can be longer than the consequent rounds of 40S recruitment and production of translating ribosomes in the pool. In the model M1 we explicitly model the step of binding of 40S and 60S subunits to mRNA. In the model M1′ we also explicitly add the binding of the initiation factors. In the model M0 'reg we introduce the effect of irreversible binding of a regulatory molecule to mRNA which can be, for example, a microRNA.
An assumption implicitly made in the simplest model M0 is that the process of the first translation initiation (on a just transcribed mRNA) takes the same amount of time as consequent translation initiations on the mRNA already having translating ribosomes. In reality, the time needed to process transcribed mRNA into the form ready for translation can take significant time, including such steps as splicing, circularization, etc.
In order to model this additional initial delay, specific states of mRNA such as R0(free mRNA) and R_0(initiated mRNA) can be separately represented in the model. Let us denote the amount of mRNA in these states as M0 =R0 and F0 =R_0 . The corresponding reaction network is shown in Figure 3. This model is able to represent specific states of just produced, non-initiated mRNA. This model contains two additional parameters:k01 and k02, which are rate constants of the first round of mRNA initiation and firing the first assembled ribosome into the pool. Evidently, these constants cannot be smaller than k1 and k2, because they include some additional events:k1 corresponds to recruiting 40S while k01 corresponds to initiating the new-born mRNA and recruiting 40S on it. Thus, typically k01 << k1.
If k02 << k2 then this can also represent translation with membrane-bound ribosomes or SRP cycle [26], when there is a transient translation arrest in the initiated monosome state (the very beginning of the translation).
Separating M0 and F0 states also allows estimating the average number of ribosomes RB sitting on an initiated mRNA (the pool represented by M and F states in M0′).
The corresponding system of equations is
{dM0dt=kt−(kd+k01)M0dF0dt=k01M0−(kd+k02)F0dMdt=k02F0+k2F−(kd+k1)MdFdt=k1M−(kd+k2)FdRdt=k02F0+k2F−(kd+krd+k3)RdPdt=k3R−kpP | (2.6) |
which has the following steady-state solution:
M0=ktk01+kd,F0=ktk01(k01+kd)(k02+kd), |
M=ktkdk01k02(k2+kd)(k01+kd)(k02+kd)(k1+k2+kd),F=ktkdk01k02k1(k01+kd)(k02+kd)(k1+k2+kd), |
R=ktkdk01k02(k1+kd)(k2+kd)(k01+kd)(k02+kd)(k1+k2+kd)(k3+kd+krd), |
P=k3kpktkdk01k02(k1+kd)(k2+kd)(k01+kd)(k02+kd)(k1+k2+kd)(k3+kd+krd), |
MT=M0+F0+M+F=ktkd, |
RB=RM+F=(k1+kd)(k2+kd)(k1+k2+kd)(k3+kd+krd). | (2.7) |
The relaxation times are
rtM0=1k01+kd,rtF0=1min(k01+kd,k02+kd), | (2.8) |
rtM=rtF=1kd,rtR=1kd,rtP=1min(kd,kp). |
The M-F subsystem has the kinetic matrix with eigenvalues – kd and – kd – k1 – k2.
One of the undesired features of the simplest translation models M0 and M0′ is a possibility of unrealistic increase of the number of translating ribosomes in the pool. The kinetic rate constants k1 and k2 implicitly include the concentrations (not amounts) of 40S and 60S subunits correspondingly. Increasing these concentrations might lead to the unlimited growth of the steady-state amount of ribosomes (2.5).
Therefore, in order to create a more detailed and realistic representation of reaction M →F, one can include the intermediate step of reversible binding of mRNA to the small ribosomal subunit M + 40S→M:40S and the scanning step during which 40S bound to mRNA search for the start codon: M:40S→F. Here Frepresents a state of mRNA with 40S positioned at the start codon and ready to recruit 60S. The time needed for finding the start codon (∼1/ ka) is a complex function of the local concentrations of certain initiation factors and, possibly, length and the secondary structure of 5'UTR.
Similar to M0′, we can decouple the two initial states of mRNA in M1 and produce the model M1′, in which binding of initiation factors can be represented explicitly (Figure 5). The process of protein synthesis involves a variety of initiation factors whose exact function can significantly differ even within the same cell. In order to avoid complications, we will abstractly denote two major types of initiation factors asIF1 and IF2. Initiation factors of type IF1 initiate mRNA by binding to the cap structure, poly-A tail, etc. In turn, IF2 initiate assembly of ribosomes and can be RNA helicases or other helper molecules [25]. IF1 factors are released only when the initiated states of mRNA (all besides M0) are degraded.IF2 are released in the end of each ribosome assembly.
It is important to make a notice on the usage and recycling of 40S, 60S and IFs. All these molecules make a pool of resources (together with ATP and GTP, aminoacids, tRNAs, etc.) shared between many protein syntheses in the whole cell. The equations (2.4), (2.6) are written down for the amounts of the corresponding proteins, while 40S, 60S and IFs are consumed with the rates proportional to their local concentrations(Figure 5). 40S, 60S and IFs moleculesare returned to the pool of cellular resources in four ways: (1) in each act of mRNA degradation (except for the just transcribed M0 state of mRNA) with rate constant kd, (2) release of ribosomes from mRNA with rate constants k3 and krd, (3) in backward reactions of 40S detachment from mRNA with rate constants k−1,k−01(not shown explicitly in Figure 5), (4) in releasing a new translating ribosome with the rate constants k2,k02.
We assume that each individual protein synthesis does not significantly change the pool of cellular resources and, therefore, the local concentrations of 40S, 60S and IFs remain constant. With such quite a realistic assumption, the models remain linear and analytically tractable. However, this might not be completely satisfactory approximation for the in vitro cell-free systems for studying translation, when the amounts of 40S or 60S or IFs are made comparable to the amounts of the translated mRNA. In this case recycling of ribosomal subunits and initiation factors might be a limiting (and fast) process, thus it should be represented explicitly, taking into account the effective volume occupied by 40S or 60S or IFs in the system (because the kinetic rates of resources release give the amount of the released translation factors while their consumption rates are proportional to their concentrations).
The steady state solution of the model M1, assuming that the ribosomal units 40S and 60S are available in excess is:
MSS=ktkdk2[60S]+kdk+1k2k−1+ka+kd[40S][60S]+kd+k2[60S]+k+1(ka+kd)k−1+ka+kd[40S] |
FSS=ktk+1kakd[40S]k+1k2[40S][60S]+kd(k−1+ka+kd)+k2(k−1+ka+kd)[60S]+k+1(ka+kd)[40S] |
(M:40S)SS=ktk+1kd[40S](k2[60S]+kd)k+1k2[40S][60S]+kd(k−1+ka+kd)+k2(k−1+ka+kd)[60S]+k+1(ka+kd)[40S] |
RSS=ktkdkak3+kd[40S][60S][40S][60S]+kd(k−1+ka+kd)k+1k2+k−1+ka+kdk+1[60S]+ka+kdk2[40S] | (2.9) |
PSS=ktkdkak3+kdk3kp[40S][60S][40S][60S]+kd(k−1+ka+kd)k+1k2+k−1+ka+kdk+1[60S]+ka+kdk2[40S] |
Let us assume that the translation process is regulated by a molecule which can irreversibly bind to mRNA and, as a result, can change one or several kinetic rates of translation. Typical example of such a molecule is microRNA [27], so we will call it like this further. MicroRNAs are short stretches of RNA, able to regulate translation of the majority of human proteins, playing an important role in normal physiological processes and diseases such as cancer [28,29].
For our purposes (representing microRNA-based regulation), it is important to distinguish states M0 and F0 to be able to represent the initiation of mRNA and the effect of microRNA on the initiation process. MicroRNA can act on k01 step (M0 → F0), thus inhibiting the early initiation process, or on k1 step (M →F), thus, inhibiting step of 40S binding on already initiated mRNA, or on k2 step ( F→M+R), thus inhibiting ribosome assembly process [20,27,30].
To take into account the action of microRNA on translation, the model of translation shown in Figure 3 is supplied with mRNA states representing mRNA with a microRNA bound to it (states M' 0 , F' 0, M', F', R'). The rate of microRNA binding iskbwhich determines irreversible conversion of the microRNA-free states (without prime) to microRNA-bound states (primed). The corresponding rate constants which might be different from normal translation process are marked with prime symbol as well. In addition, we introduce a special state B which describes reversible capturing of mRNA in P-bodies, where they can be specifically degraded at a higher ratekbdthan during the microRNA-free translation (Figure 6A).
The modelM0′ reg model was used in [27] to produce the kinetic signatures of nine different mechanisms of microRNA action or their combinations. It was shown that each of the nine possible mechanisms has its own characteristic kinetic signature, which gives to experimentalists a tool to discriminate between them in their particular experimental system. The provided characteristic kinetic signature of an individual mechanism represents a characteristic plot with the predicted dynamics of 3 measurable biochemical variables (mRNA concentration, the corresponding protein concentration, the average number of ribosomes at a translated mRNA) in the case when a microRNA act on a given mRNA via this exact mechanism only.
The model M0′ reg was used in [27] to shed light on certain controversies in the experimental detection of a concrete mechanism of microRNA action. It was suggested that the actual observable mechanism depends on the rate-limiting steps in the complex translation machinery. For rather complex reaction mechanisms such as M0′ reg, the notion of the rate-limiting step should be replaced by the dominant system [34]. Analysis of M0′ reg showed existence of 6 dynamic types (dominant systems) each of which can correspond to several biological mechanisms of microRNA action. These dynamic types are: unmodified translation without strong effect from microRNA (Figure 6B), rapid degradation of mRNA after microRNA binding (Figure 6C), exporting mRNA to specialized compartments with further degradation (Figure 6D), limiting ribosomal assembly step (Figure 6E), limiting translation termination step (Figure 6F), translation of a relatively stable mRNA affected by the presence of microRNA (Figure 6G). These dynamic translation regulation types are discussed in more details in [27]. In all scenario, the mRNA degradation rate constant plays an important role in defining the rate limiting steps.
The basic lumped model can serve as a basis for other model extensions by explicit splitting of particular states from the lumped states and other modifications. Let us list several possible scenarios:
1. More explicit representation of translation termination or elongation, description of ribosome stalling phenomenon.
2. More detailed representation of the mRNA initiation process. For example, formation of the M0:IF1:40S complex in Figure 6 should proceed in several elementary steps, with particular role and order of binding of scaffold initiation proteins and other initiation factors, with subsequent recruitment of 40S.
3. Description of phenomena connected with uneven distribution of ribosomes along mRNA, such as described in recent literature on explicit studies of ribosome positioning on mRNAs [31].
4. Explicit modeling of the mRNA codon usage.
5. Mean-field models of the ribosomes' interaction: The simplest method to include the interaction of ribosomes in the lumped model is a dependence of the ribosome drop-off constant krd on the average concentration θ of the ribosomes per initiated molecule of mRNA: krd = krd (θ). For example, for the scheme presented in Figure 3 it may be krd (θ) = a/(b– θ), where θ = R/(M+F).
6. Mean-field models of how the property of the mRNA (such as its stability) might change depending on the state and also on the history of mRNA. For example, one can imagine a (very hypothetical) version of mRNA kinetics with "mRNA aging" such as each new round of translation makes mRNA more fragile and prone to destruction. Or, in opposite, mRNA can become more stable with ribosomes sitting on it.
7. Modeling distribution of model parameters, leading to existence of population of mRNAs with different speeds of different steps of translation.
8. Explicit modeling of competition of various protein syntheses processes for resources (ribosomal subunits and initiation factors). The most interesting is to include in this picture the production of the resources themselves (transcription, translation, degradation), which will introduce complex global regulatory feedbacks.
In order to illustrate what distinguishes two particular translation models described above, we performed a numerical experiment in which we varied the concentrations of ribosomal subunits and studied their effect on the average number of translating ribosomes per mRNA. We compared two models M0′ and M1′, without and with an intermediate state of mRNA bound to 40S ribosomal subunit but with 40S not yet positioned at the start codon. Our purpose is to demonstrate two points: (1) that the step of late initiation might be very sensitive parameter and lead to efficient regulation of translation (which is consistent with experimental findings [32]; (2) that without this step a simpler model M0′ can lead to non-physiological unlimited growth of translating ribosomes per mRNA (Figure 7).
As one can see from Figure 7, the steady state value of the average number of translating ribosomes per mRNA is not limited in the model M0′, if the concentrations of small and large ribosomal subunits are increased simultaneously. Increasing only concentration of 60S with fixed concentration of 40S is not sufficient: to increase the number of complexes one has to supply the system with both components.
By contrast, in the model M1′, simultaneous increase in the concentrations of 40S and 60S makes RB insensitive to them (Figure 7, right plot). This can be easily understood from the model shown in Figures 4 and 5. If one assumes that the rates of mRNA degradation and synthesis are slower than the translation rate then it is easy to show that the steady-state value of the average number of translating ribosomes per mRNA is
RB=1k3×kak+1k2[IF1][IF2][40S][60S]k2[60S](ka[IF2]+k−1)+k+1[IF1][40S](k2[60S]+ka[IF2]). |
Hence, if both ribosomal subunits are in excess then
RB|[60S],[40S]→∞=ka[IF2]k3. | (2.10) |
This is the limiting value of the average number of translating ribosomes per mRNA in the models M1 and M1′.
Formula (2.10) has an important biological consequence: in the excess of ribosomal subunits the most sensitive parameter of protein synthesis (which is determined by RB) is the availability (or, equivalently, efficiency) of the initiation factors facilitating fixation of 40S bound to mRNA at the start codon (collectively denoted as IF2 in Figure 6). Good candidates for this type of initiation factors are RNA helicases whose role is to disentangle the 5'UTR regions of mRNA [25,32]. The early initiation factors, collectively denoted as IF1 in Figure 6, can play less important role, if the ribosomal subunits are in excess (they do not enter into (2.10)).
If both initiation factors are in excess, then there is saturation with respect to their values. For fixed concentrations of the ribosomal subunits we get
RB|[IF1],[IF2]→∞=k2[40S][60S]k3. |
Therefore, saturation with respect to ribosomal subunits and initiation factor concentrations is not symmetric: the limiting parameter value with respect to infinite increase of initiation factors depends on both 40S and 60S concentrations while the limiting value with respect to infinite increase of ribosomal subunits depends only on the concentration of IF2.
Models developed in the previous sections can help understand general and global properties of protein synthesis in a living cell. Instead of focusing on a single protein synthesis, one can consider a global machinery of synthesis of all cellular proteins or some abundant groups of them.
Therefore, it is interesting to consider applying the basic model of protein synthesis to the model the synthesis of ribosomal proteins, because in this case there exists an intrinsic feedback mechanism regulating the amount of ribosomal proteins in a living cell.
At first, we exploited for this purpose model M1(Figure 4) which suggests how in a quasi-steady state the number of translating ribosomes RSS depends on the concentrations of 40S and 60S components (see formula (2.9)). Assuming physiological translation (efficient binding of 40S to mRNA and not too strong mRNA degradation), we can put ka>>k−1,kd<<ka,kd<<k3 and simplify (2.9) to
RSS=ktkdkak3[40S][60S][40S][60S]+kdkak+1k2+kak+1[60S]+kak2[40S]=kak3MRS[40S][60S][40S][60S]+nm+m[60S]+p[40S], | (2.11) |
where MRS=ktkd,m=kak+1,n=kdk2,p=kak2. The meaning of MRS parameter is the total number of mRNAs of a given protein or a protein type.
In order to study very general features of ribosomal protein synthesis, let us assume that [40S] and [60S] components are identical and denote them collectively as S=[40S] = [60S] and use the rate equation (2.11) :
dSdt=kaMRSS2S2+(p+m)S+mn−ksS | (2.12) |
The equation (2.12) is characterized by a possibility of bistability, with two non-zero steady states (one of which is stable and another one is unstable):
SHigh=12[MRSkaks−(p+m)+√(MRSkaks−(p+m))2−4mn] |
SLow=12[MRSkaks−(p+m)−√(MRSkaks−(p+m))2−4mn] |
Three steady states of the protein synthesis system (S = 0, S = SHigh, S = SLow) exist only when
(MRSkaks−(p+m))2≥4mn, | (2.13) |
which we can consider as a general condition of cell viability, because otherwise sustainable protein synthesis is not possible.
In the important asymptotic case (MRSkaks−(p+m))2>>4mn, one has
SHigh≈MRSkaks−(p+m)=ka(ktkd1ks−1k2−1k+1), |
SLow≈mnMRSkaks−(p+m)=kdktkdk+1k2ks−(k+1+k2). | (2.14) |
The meaning of SLow is the minimum number of ribosomes needed to maintain the translation (when it is possible, accordingly to the condition (2.13)). If the number of ribosomes drops below this threshold, then the translation will collapse to the zero steady state (Figure 8A). Interestingly, in the asymptotic case (2.14), SLow decreases with increasing efficiency of translation initiation (k+1, k2 coefficients) and does not depend on ka.SHigh, which meaning is the stable number of ribosomes in a cell, has the opposite behavior: it increases with more efficient translation and linearly scales with the scanning rate ka. This behavior is illustrated in (Figure 8B) for some realistic estimation of the protein synthesis parameters.
This analysis shows that for a biologically relevant set of parameters, the critical necessary minimal number of ribosomes in a cell seems not to exceed few thousands. It becomes larger in the case when the ribosomal protein translation is slow due to its rate limiting initiation. For large intervals of values of initiation rates, the critical amount can approach 1 ribosome, which means that theoretically, a cell can recover from drastic (close to complete) ribosome depletion, by synthesizing a new complete pool of them. As a strong speculation, one can suggest that evolutionary the parameters of translation are chosen such that a cell could robustly recover its protein synthesis machinery.
Numerical simulations were made using MATLAB. Executable model definitions are provided from http://github.com/sysbio-curie/ProteinTranslationModels.
Rough parameter estimation was made using numbers from [33] and http://book.bionumbers.org, using data for a simple eukaryotic cell, such as yeast. Typical mRNA half-life was assumed in 20–30 minutes, which is reflected in the value kd = 8⋅10−4 sec −1. The number of mRNA molecules for a particular protein was estimated on average in 1000, which leads in kt = 10 3kd. Typical protein half-life was assumed in 30–60 mins which gives ks = 4⋅10−4 sec −1. We assumed the stable number of ribosomes in a cell in 2−5⋅105 which constrains the value SHigh and the protein/mRNA ratio in 10 2 by the order of magnitude. For other parameter values (k+1, k2, ka ) we did not fix the exact parameters but rather scan their ranges, assuming that the initiation of mRNA with 40S is faster than full ribosome assembly (k+1 = 10 k2 ) and that the 5' scanning step is relatively fast (ka >> k+1). We underline here that these parameter values' choice does not change the formulas derived in the manuscript and the conclusions about the model's dynamic behavior but rather used for illustrative purpose.
The meaning of different kinetic parameters introduced in different protein synthesis models is specified in Table 1.
Parameter | Model(s) | Parameter meaning in a specific model and relation to other parameters |
kT | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of transcription process |
k1 | M 0, M 0', M 0'reg | Rate constant of translation initiation. It includes the 40S subunit binding and scanning for the start codon. In the simplest model M 0 it denotes both the rate of the first round of initiation and all further initiation events on already translated mRNA. |
k2 | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of ribosome assembly, including possible transient arrest of ribosomes before starting translation. |
k3 | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of translation elongation step; it also includes the rate of translation termination |
kd | M 0, M 0', M 1, M 0'reg | Rate constant of mRNA degradation |
krd | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of premature ribosomal drop-off from translated mRNA |
kp | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of protein degradation |
k01 | M 0', M 0'reg | Rate constant of the first round mRNA initialization and binding of the 40S subunit including specific steps of initialization |
k02 | M 0', M 1' | Rate constant of the first round of ribosomal assembly on initiated mRNA |
k+1, k−1 | M 1, M 1' | Rate constants of reversible binding of 40S subunit to mRNA |
ka | M 1, M 1' | Rate constant of 40S subunit scanning of 5'UTR for the start codon. In the model M 1' it includes binding of factors facilitating the scanning, collectively denoted as IF2 |
k+01, k−01 | M 1' | Rate constants of reversible binding of both translation initiation factors, collectively denoted as IF1 and 40S to the naked mRNA (first round of initialisation) |
k b | M 0'reg | Rate constant of irreversible binding of a regulatory molecule (such as microRNA) to mRNA |
k+s, k−s | M 0'reg | Rate constant of reversible capturing of mRNA to a compartment (such as P-bodies) where the translation is inhibited |
kbd | M 0'reg | Rate constant of degradation of mRNA in a compartment where the translation is inhibited |
In this paper we introduce several simple models of protein synthesis which are directly derived from a simplification of detailed kinetics of protein translation, describing the phenomenon of polysome. The simplification is achieved through lumping, one of the common approaches from reaction network asymptotology toolbox [34]. This derivation distinguishes the model from other simpified models of protein synthesis introduced ad hoc in various studies. Simple explanatory illustration of the nature of the suggested model is provided in Figure 9 ("opening/closing door"-type modeling).
When introducing the protein synthesis model, we used notions and terms specific to eukaryotes (e.g., we explicitly named the risobomal subunits 40S and 60S). In the current form, the model is indeed directly applicable to describing the translation in a typical eukaryotic cell. Adapting the model to translation in prokaryotes is possible though it will require to take into account such phenomena as translation from polycistronic mRNA, spatio-temporal coupling of DNA replication, transcription and translation processes, and other effects.
The main use of simple and basic models of protein synthesis is identification of sensitive (e.g., rate limiting) parameters of the protein synthesis machinery, whose change can efficiently regulate translation. In the past, such an approach was used by us in order to identify the mechanisms of microRNA action by following through the dynamics of the basic observables of translation: amount of mRNA, amount of protein and the polysomal profile, in the presence and in the absence of microRNA. An unsolved inverse problem remains in the case when a regulatory molecule (such as a microRNA) can affect simultaneously several translation parameters. In this case, it is desirable to have an effective mathematical tool allowing "deconvoluting" the mixed effect of the regulation into a vector of strengths of individual translation parameter modulations.
The model is made extendable such that it makes it relatively easy to represent in more details some particular aspects of protein synthesis dynamics, if this is needed. We provide several model extensions, each of which can have specific applications. One of such extension deals with a feature of the basic model which might be non-desirable: namely, a possibility for unlimited number of ribosomes in a polysome. Explicit representation of a reaction step describing the scanning by the 40S ribosomal subunit for the start codon along the 5' end of mRNA limits the number of ribosomes in polysome and allows determining the most sensitive parameters of translation initiation under various assumptions (e.g., for the case of unlimited access of 40S and 60S subunits).
Another example of application that we provided is modeling the synthesis of ribosomal protein pool in a cell. We demonstrate that in this cellular system there exists an intrinsic bi-stability, with three steady-states for the amount of ribosomes in a cell, two stable ones, 0 and SHigh, and one unstable SLow. We derive formulas for these values connecting them to the basic parameters of protein synthesis. The biological meaning of SLow is the minimum number of ribosomes required for a cell in order to sustain its protein synthesis. If the number of ribosomes drops below this number, then the whole machinery of protein synthesis is predicted to collapse, not being able to maintain the synthesis of ribosomal protein pool. Interestingly, the usual estimates for the number of ribosomes in a living cell is made for the case of actively proliferating cells using simple arguments for the necessity of protein pool replenishment in dividing cells [33]. By contrast, the estimates for SHigh(stable number of ribosomes) and SLow(minimum number of ribosome state from which the protein synthesis is able to recover) are valid even for quiescent cells. It is known that the house-keeping proteins have relatively long half-lives: therefore, sustaining cellular life can less crucially depend on the de novo protein synthesis and availability of the ribosomal proteins.
For quiescent cells, the experiment with depleting the ribosomal protein pool might be feasible in theory. We must notice that in a real cell even transitory depletion of the ribosomal pool might be incompatible with cell viability for multiple other reasons not directly related to the bistability and collapse of the protein synthesis machinery. Also, the parameter estimations of the protein synthesis model used in this study might be grossly inaccurate. Nevertheless, the theoretical conclusion on the existence of the critical minimum number of ribosomes is independent on the parameter values, and can be potentially validated in an experiment.
The model of ribosomal protein synthesis suggested in this paper needs to be completed with equations describing the synthesis of non-ribosomal proteins. Also, distinguishing 40S and 60S ribosomal proteins might lead to the new interesting dynamical effects such as existence of oscillations in protein synthesis machinery, which potentially can lead to periodic change in the cellular dry mass, even in the absence of proliferation. Exploration of such model extensions, with construction of their complete parametric portrait is beyond the score of this paper but is a feasible though a difficult task.
One particular application of the translation models consists in deciphering the results of application of modern sequencing-based technologies quantifying the global state of the translational machinery, such as Ribo-Seq or TRAP-Seq [35]. The amount of data of this type (translatomic data) rapidly grows, but remains less ready for intuitive interpretation compared to other omics data types and require mathematical modeling, taking into account various aspects of polysome [36].
To conclude, the introduced mathematical models of protein synthesis can find applications in modeling and data analysis when the most detailed representation of the translation mechanisms is not required.
This study was partially supported by ITMO Cancer "Non-coding RNA in cancerology" program (project "Using an integrative strategy to decipher miRNAs function in Pediatric Brain Tumor") and by the Ministry of Science and Higher Education of the Russian Federation (Project No. 14.Y26.31.0022).
The authors declare that there is no conflict of interest regarding the publication of this article.
[1] |
Lucchinetti CF, Brück W, Rodriguez M, et al. (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6: 259-274. https://doi.org/10.1111/j.1750-3639.1996.tb00854.x ![]() |
[2] |
Peterson JW, Trapp BD (2005) Neuropathobiology of multiple sclerosis. Neurol Clin 23: 107-129. https://doi.org/10.1016/j.ncl.2004.09.008 ![]() |
[3] |
Weissert R (2013) The Immune Pathogenesis of Multiple Sclerosis. J Neuroimmune Pharmacol 8: 857-866. https://doi.org/10.1007/s11481-013-9467-3 ![]() |
[4] |
Walton C, King R, Rechtman L, et al. (2020) Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler 26: 1816-1821. https://doi.org/10.1177/1352458520970841 ![]() |
[5] |
Bakirtzis C, Grigoriadou E, Boziki MK, et al. (2020) The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database. Front Neurol 11: 1012. https://doi.org/10.3389/fneur.2020.01012 ![]() |
[6] | Geneva WHO.Health promotion glossary. WHO, (document WHO/HPR/HEP/98.1) (1998) . |
[7] | de Wit M, Hajos T (2013) Health-Related Quality of Life. Encyclopedia of Behavioral Medicine . New York, NY: Springer. https://doi.org/10.1007/978-1-4419-1005-9_753 |
[8] | Health-Related Quality of Life (HRQOL) CDC (2021). Available from: https://www.cdc.gov/hrqol/index.htm |
[9] |
Benito-León J, Morales JM, Rivera-Navarro J, et al. (2003) A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil 25: 1291-1303. https://doi.org/10.1080/09638280310001608591 ![]() |
[10] | Tzenalis A, Tsoungou G, Bellali T (2016) Psychosocial dimensions and quality of life of patients with multiple sclerosis: A literature review from 2000-2015. Hellenic J Nursing Sci 9: 17-29. |
[11] |
Janzen W, Turpin KV, Warren SA, et al. (2013) Change in the health-related quality of life of multiple sclerosis patients over 5 years. Int J MS Care 15: 46-53. https://doi.org/10.7224/1537-2073.2012-020 ![]() |
[12] |
Vasconcelos AG, Haase VG, Lima EDP, et al. (2010) Maintaining quality of life in multiple sclerosis: fact, fiction, or limited reality?. Arquivos de neuro-psiquiatria 68: 726-730. https://doi.org/10.1590/S0004-282X2010000500010 ![]() |
[13] |
Pashazadeh KF, Hoseinipalangi Z, Ahmadi N, et al. (2022) Global, regional and national quality of life in patients with multiple sclerosis: a global systematic review and meta-analysis. BMJ Support Palliat 12: 158-166. http://dx.doi.org/10.1136/bmjspcare-2020-002604 ![]() |
[14] |
Amtmann D, Bamer AM, Kim J, et al. (2018) People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures. Disabil Health J 11: 99-107. https://doi.org/10.1016/j.dhjo.2017.04.008 ![]() |
[15] |
Brola W, Sobolewski P, Fudala M, et al. (2016) Self-reported quality of life in multiple sclerosis patients: preliminary results based on the Polish MS Registry. Patient Prefer Adher 10: 1647. https://doi.org/10.2147/PPA.S109520 ![]() |
[16] | Šabanagić-Hajrić S, Alajbegović A (2015) Impacts of education level and employment status on health-related quality of life in multiple sclerosis patients. Med Glas (Zenica) 12: 61-67. |
[17] |
Tepavcevic DK, Pekmezovic T, Stojsavljevic N, et al. (2014) Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study. Qual Life Res 23: 1027-1037. https://doi.org/10.1007/s11136-013-0535-1 ![]() |
[18] |
Oleen-Burkey M, Castelli-Haley J, Lage MJ, et al. (2012) Burden of a multiple sclerosis relapse. Patient 5: 57-69. https://doi.org/10.2165/11592160-000000000-00000 ![]() |
[19] |
Ochoa-Morales A, Hernández-Mojica T, Paz-Rodríguez F, et al. (2019) Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability. Mult Scler Relat Disor 36: 101386. https://doi.org/10.1016/j.msard.2019.101386 ![]() |
[20] |
Berrigan LI, Fisk JD, Patten SB, et al. (2016) CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS). Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity. Neurology 86: 1417-1424. https://doi.org/10.1212/WNL.0000000000002564 ![]() |
[21] |
Hanna M, Strober LB (2020) Anxiety and depression in multiple sclerosis (MS): antecedents, consequences, and differential impact on well-being and quality of life. Mult Scler Relat Disor 44: 102261. https://doi.org/10.1016/j.msard.2020.102261 ![]() |
[22] |
Kotan VO, Kotan Z, Aydin B, et al. (2019) The relationship between psychopathology, psychosocial adjustment, social support and quality of life in multiple sclerosis. Eur Res J 5: 20-28. http://dx.doi.org/10.18621/eurj.382894 ![]() |
[23] |
Krstić D, Krstić ZD, Stojanović Z, et al. (2021) The influence of personality traits and coping strategies on the quality of life of patients with relapsing-remitting type of multiple sclerosis. Vojnosanitetski Preg 78. https://doi.org/10.2298/VSP190502132K ![]() |
[24] |
Nery-Hurwit M, Yun J, Ebbeck V (2018) Examining the roles of self-compassion and resilience on health-related quality of life for individuals with Multiple Sclerosis. Disabil Health J 11: 256-261. https://doi.org/10.1016/j.dhjo.2017.10.010 ![]() |
[25] | Kabat-Zinn J, Hanh TN (2009) Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness. Delta. |
[26] |
Kolahkaj B, Zargar F, Majdinasab N (2019) The effect of mindfulness-based stress reduction (MBSR) therapy on quality of life in women with multiple sclerosis, Ahvaz, Iran. J Caring Sci 8: 213. https://doi.org/10.15171/jcs.2019.030 ![]() |
[27] | Brajković L, Braš M, Milunović V, et al. (2009) The connection between coping mechanisms, depression, anxiety and fatigue in multiple sclerosis. Coll Antropol 33: 135-140. |
[28] |
Broersma F, Oeseburg B, Dijkstra J, et al. (2018) The impact of self-perceived limitations, stigma and sense of coherence on quality of life in multiple sclerosis patients: results of a cross-sectional study. Clin Rehabil 32: 536-545. https://doi.org/10.1177/0269215517730670 ![]() |
[29] |
Albuquerque SC, Carvalho ER, Lopes RS, et al. (2011) Ego defense mechanisms in COPD: impact on health-related quality of life and dyspnoea severity. Qual Life Res 20: 1401-1410. https://doi.org/10.1007/s11136-011-9884-9 ![]() |
[30] |
Hyphantis TN, Tsifetaki N, Siafaka V, et al. (2007) The impact of psychological functioning upon systemic sclerosis patients' quality of life. Semin Arthritis Rheu 37: 81-92. http://dx.doi.org/10.1016/j.semarthrit.2007.03.008 ![]() |
[31] |
Goulia P, Voulgari PV, Tsifetaki N, et al. (2015) Sense of coherence and self-sacrificing defense style as predictors of psychological distress and quality of life in rheumatoid arthritis: a 5-year prospective study. Rheumatol Int 35: 691-700. https://doi.org/10.1007/s00296-014-3134-8 ![]() |
[32] |
Hyphantis T, Palieraki K, Voulgari PV, et al. (2011) Coping with health-stressors and defence styles associated with health-related quality of life in patients with syste-mic lupus erythematosus. Lupus 20: 893-903. https://doi.org/10.1177/0961203311398264 ![]() |
[33] | Freud S (1894) The neuro-psychoses of defence. Standard Edition, 3, 45–61. London: Hogharth Press, 1962. |
[34] |
Cramer P (2015) Understanding defense mechanisms. Psychodyn Psychiatry 43: 523-52. https://doi.org/10.1521/pdps.2015.43.4.523 ![]() |
[35] |
Cramer P (1987) The development of defense mechanisms. J Pers 55: 597-614. https://doi.org/10.1111/j.1467-6494.1987.tb00454.x ![]() |
[36] |
Vaillant GE (1967) Natural history of male psychological health. V. The relation of choice of ego mechanisms of defence to adult adjustment. Arch Gen Psychiatry 33: 535-45. https://doi.org/10.1001/archpsyc.1976.01770050003001 ![]() |
[37] |
Flannery RB, Perry JC (1990) Self-rated defence style, life stress, and health status: An empirical assessment. Psychosomatics 31: 313-320. https://doi.org/10.1016/S0033-3182(90)72169-X ![]() |
[38] |
Vaillant GE (2000) Adaptive mental mechanisms: Their role in a positive psychology. Am Psychol 55: 89-98. https://doi.org/10.1037//0003-066X.55.1.89 ![]() |
[39] |
Bond M, Christian J, Sigal JJ (1983) Empirical Study of Self-rated Defense Styles. Arch Gen Psychiatry 40: 333-338. https://doi.org/10.1001/archpsyc.1983.01790030103013 ![]() |
[40] |
Hyphantis TN, Triantafillidis JK, Pappa S, et al. (2005) Defense mechanisms in inflammatory bowel disease. J Gastroenterol 40: 24-30. https://doi.org/10.1007/s00535-004-1491-x ![]() |
[41] | Hyphantis T, Katsoudas S, Voudiclari S (2010) Ego mechanisms of defense are associated with patients' preference of treatment modality independent of psychological distress in end-stage renal disease. Pat Pref Adh 4: 25-32. https://doi.org/10.2147/PPA.S7796 |
[42] |
Beresford TP, Alfers J, Mangum L, et al. (2006) Cancer survival probability as a function of ego defense (adaptive) mechanisms versus depressive symptoms. Psychosomatics 47: 247-253. https://doi.org/10.1176/appi.psy.47.3.247 ![]() |
[43] |
Kreitler S (2004) Defense mechanisms and physical health. Advances in Psychology . Elsevier 477-519. https://doi.org/10.1016/S0166-4115(04)80046-3 ![]() |
[44] |
Metzger JA (2014) Adaptive defense mechanisms: function and transcendence. J Clin Psychol 70: 478-88. https://doi.org/10.1002/jclp.22091 ![]() |
[45] |
Malone JC, Cohen S, Liu SR, et al. (2013) Adaptive midlife defense mechanisms and late-life health. Pers Individ Dif 55: 85-89. https://doi.org/10.1016/j.paid.2013.01.025 ![]() |
[46] | Kimmel J A comparison of children with congenital and acquired orthopedic handicaps on certain personality characteristics: An evaluation of self-concept, anxiety, defense mechanisms, and adjustment in children with orthopedic handicaps. New York University (1958). |
[47] |
Passchier J, Goudswaard P, Orlebeke JF, et al. (1988) Migraine and defence mechanisms: psychophysiological relationships in young females. Soc Sci Med 26: 343-50. https://doi.org/10.1016/0277-9536(88)90399-1 ![]() |
[48] |
Monsen K, Havik OE (2001) Psychological functioning and bodily conditions in patients with pain disorder associated with psychological factors. Bri J of Med Psychol 74: 183-195. https://doi.org/10.1348/000711201160902 ![]() |
[49] | Mazza S, Pinkus L, Caviglia G, et al. (1994) A psychological approach model to neurological chronic illness: Epilepsy and multiple sclerosis. Archivio di Psicologia, Neurologia e Psichiatria 55: 791-795. |
[50] | Caviglia G, Crisi A, Azzoni A, et al. (1990) The mechanisms of repression and isolation in multiple sclerosis as regulators of personality system: a clinical study. Schweiz Arch Neurol Psychiatr 141: 209-15. |
[51] |
Snowden JS, Craufurd D, Griffiths HL, et al. (1998) Awareness of involuntary movements in disease. Arch Neurol 55: 801-5. https://doi.org/10.1001/archneur.55.6.801 ![]() |
[52] |
Pervichko E, Zinchenko Y (2014) Ego Defense Mechanisms in Patients with “Hypertension at Work” and Patients with Essential Hypertension: A Comparative Analysis. Procedia - Soc Behav Sci 127: 666-670. https://doi.org/10.1016/j.sbspro.2014.03.332 ![]() |
[53] | Xu Z, Fan X, Hu P, et al. (1996) Study of type II diabetes mellitus behavioral pattern. Acta Psych Sin 28: 315-319. |
[54] | Rotenberg VS, Michailov AN (1993) Characteristics of psychological defense mechanisms in healthy testees and in patients with somatic disorders. Homeostasis Health Dis 34: 54-58. https://doi.org/10.1016/0010-440X(93)90036-4 |
[55] | Conversano C, Di Giuseppe M, Miccoli M, et al. (2020) Retrospective Analyses of Psychological Distress and Defense Style Among Cancer Patients. Clin Neuropsychiatry 17. https://doi.org/10.36131/cnfioritieditore20200403 |
[56] | Setareh J, Monajemi MB, Abedini M, et al. (2017) Comparing Defense Mechanisms, Resilience and Cognitive Distortion of Patients with Multiple Sclerosis and Healthy Individuals. Glob J Health Sci 9. https://doi.org/10.5539/gjhs.v9n10p44 |
[57] |
Hyphantis T, Christou K, Kontoudaki S, et al. (2008) Disability status, disease parameters, defense styles, and ego strength associated with psychiatric complications of multiple sclerosis. Int J Psychiatry Med 38: 307-27. https://doi.org/10.2190/PM.38.3.g ![]() |
[58] | Alvani SR, Hosseini SMP, Alvani S (2012) Living with chronic illnesses and disability. Int J Sci Technol Humanit 2: 102-110. |
[59] |
Bai M, Tomenson B, Creed F, et al. (2009) The role of psychological distress and personality variables in the disablement process in rheumatoid arthritis. Scand J Rheumatol 38: 419-30. https://doi.org/10.3109/03009740903015135 ![]() |
[60] |
Talepasand S, Mahfar F (2018) Relationship between defense mechanisms and the quality of life in women with breast cancer. Int J Cancer Manag 11. https://doi.org/10.5812/ijcm.11116 ![]() |
[61] |
Tutoglu A, Boyaci A, Karababa IF, et al. (2015) Psychological defensive profile of sciatica patients with neuropathic pain and its relationship to quality of life. Z Rheumatol 74: 646-51. https://doi.org/10.1007/s00393-014-1527-4 ![]() |
[62] |
Hyphantis TB, Bai M, Tsianos E, et al. (2010) Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients. Dig Dis Sci 55: 724-32. https://doi.org/10.1007/s10620-009-0762-z ![]() |
[63] | Antonovsky A (1985) The life cycle, mental health and the sense of coherence. Isrl J Psychiatry Relat Sci 22: 273-280. |
[64] | Antonovsky A (1987) Unravelling the mystery of health: how People Manage Stress and Stay Well. San Francisco: Josey Bass Publishers. |
[65] | Eriksson M (2022) The sense of coherence: The concept and its relationship to health. The Handbook of Salutogenesis . Springer. https://doi.org/10.1007/978-3-030-79515-3_9 |
[66] |
Kim HS, Nho JH, Nam JH (2021) A serial multiple mediator model of sense of coherence, coping strategies, depression, and quality of life among gynecologic cancer patients undergoing chemotherapy. Eur J Oncol Nurs 54: 102014. https://doi.org/10.1016/j.ejon.2021.102014 ![]() |
[67] |
Tan JY, Tam WSW, Goh HS, et al. (2021) Impact of sense of coherence, resilience and loneliness on quality of life amongst older adults in long-term care: a correlational study using the salutogenic model. J Adv Nurs 77: 4471-4489. https://doi.org/10.1111/jan.14940 ![]() |
[68] |
Ebrahimi Meymand HA, Askarizadeh G, Bagheri M, et al. (2020) The Role of Spiritual Intelligence, Sense of Coherence, and Cognitive Flexibility as Internal Resources in Predicting Perceived Stress in Patients With Multiple Sclerosis. Horizon Med Sci 27: 114-129. https://doi.org/10.32598/hms.27.1.2986.2 ![]() |
[69] |
Kristofferzon ML, Engström M, Nilsson A (2018) Coping mediates the relationship between sense of coherence and mental quality of life in patients with chronic illness: a cross-sectional study. Qual Life Res 27: 1855-1863. https://doi.org/10.1007/s11136-018-1845-0 ![]() |
[70] | Jackson DD (1957) The question of family homeostasis. Psychiatr Q Suppl 31: 79-90. |
[71] |
Rosland AM, Heisler M, Piette JD (2012) The impact of family behaviors and communication patterns on chronic illness outcomes: a systematic review. J Behav Med 35: 221-239. https://doi.org/10.1007/s10865-011-9354-4z ![]() |
[72] |
Trief PM, Grant W, Elbert K, et al. (1998) Family environment, glycemic control, and the psychosocial adaptation of adults with diabetes. Diabetes Care 21: 241-245. https://doi.org/10.2337/diacare.21.2.241 ![]() |
[73] |
Edelstein J, Linn MW (1985) The influence of the family on control of diabetes. Soc Sci Med 21: 541-544. https://doi.org/10.1016/0277-9536(85)90038-3 ![]() |
[74] |
Chesla CA, Fisher L, Mullan JT, et al. (2004) Family and disease management in African-American patients with type 2 diabetes. Diabetes Care 27: 2850-5. https://doi.org/10.2337/diacare.27.12.2850 ![]() |
[75] |
Fisher L, Chesla CA, Chun KM, et al. (2004) Patient-appraised couple emotion management and disease management among Chinese American patients with type 2 diabetes. J Fam Psych 18: 302-310. https://doi.org/10.1037/0893-3200.18.2.302 ![]() |
[76] |
Mendes TPG, Crespo CAM, Austin JK (2016) Family Cohesion and Adaptation in Pediatric Chronic Conditions: The Missing Link of the Family's Condition Management. J Child Fam Stud 25: 2820-2831. https://doi.org/10.1007/s10826-016-0447-0 ![]() |
[77] |
Moreira H, Frontini R, Bullinger M, et al. (2014) Family Cohesion and Health-Related Quality of Life of Children with Type 1 Diabetes: The Mediating Role of Parental Adjustment. J Child Fam Stud 23: 347-359. https://doi.org/10.1007/s10826-013-9758-6) ![]() |
[78] |
Pereira MG, Berg-Cross L, Almeida P, et al. (2008) Impact of family environment and support on adherence, metabolic control, and quality of life in adolescents with diabetes. Int J Behav Med 15: 187-193. https://doi.org/10.1080/10705500802222436 ![]() |
[79] |
Marks SF, Millard RW (1990) Nursing assessment of positive adjustment for individuals with multiple sclerosis. Rehabilitation Nurs 15: 147-151. https://doi.org/10.1002/j.2048-7940.1990.tb01458.x ![]() |
[80] | Moos RH, Moos BS (1994) Family Environment Scale manual. Consulting Psychologists Press. |
[81] |
Thompson AJ, Banwell BL, Barkhof F, et al. (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology 17: 162-173. https://doi.org/10.1016/s1474-4422(17)30470-2 ![]() |
[82] |
Kurtzke JF (2008) Historical and clinical perspectives of the expanded disability status scale. Neuroepidemiology 31: 1-9. https://doi.org/10.1159/000136645 ![]() |
[83] |
Vickrey BG, Hays RD, Harooni R, et al. (1995) A health-related quality of life measure for multiple sclerosis. Qual Life Res 4: 187-206. https://doi.org/10.1007/bf02260859 ![]() |
[84] |
Hyphantis T (2010) The Greek version of the Defense Style Questionnaire: psychometric properties in three different samples. Compr Psychiatry 51: 618-629. https://doi.org/10.1016/j.comppsych.2010.03.005 ![]() |
[85] |
Vaillant GE (1971) Theoretical hierarchy of adaptive ego mechanisms: A 30-year follow-up of 30 men selected for psychological health. Arch Gen Psychiatry 24: 107-118. https://doi.org/10.1001/archpsyc.1971.01750080011003 ![]() |
[86] |
Hyphantis T, Goulia P, Floros GD, et al. (2011) Assessing ego defense mechanisms by questionnaire: psychometric properties and psychopathological correlates of the Greek version of the Plutchik's Life Style Index. J Pers Assess 93: 605-617. https://doi.org/10.1080/00223891.2011.608759 ![]() |
[87] | Plutchik R, Conte HR (1989) Measuring emotions and their derivatives: Personality traits, ego defenses and coping styles. Contemporary approaches to psychological assessment (pp. 239–269) . Brunner-Mazel. |
[88] | Karalis I, Langius A, Tsirogianni M, et al. (2004) The translation-validation of the sense of coherence scale into Greek and its use in primary health care. Arch Hell Med 21: 195-203. |
[89] | Charalampous K, Kokkinos CM, Panayiotou G (2013) The Family Environment Scale: Resolving psychometric problems through an examination of a Greek translation. Int J 13. |
[90] | Giannakou M, Roussi P, Kosmides ME, et al. (2013) Adaptation of the Beck Depression Inventory-II to Greek population. Hell J Psychol 10: 120-146. |
[91] |
Fountoulakis KN, Papadopoulou M, Kleanthous S, et al. (2006) Reliability and psychometric properties of the Greek translation of the State-Trait Anxiety Inventory form Y: preliminary data. Ann Gen Psychiatr 5: 2. https://doi.org/10.1186/1744-859X-5-2 ![]() |
[92] | IBM CorpReleased 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp. |
[93] |
Mäurer M, Comi G, Freedman MS, et al. (2016) Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life: a post hoc analysis of the TEMSO and TOWER studies. Mult Scler Relat Dis 7: 33-40. https://doi.org/10.1016/j.msard.2016.02.012 ![]() |
[94] |
Schmidt S, Jöstingmeyer P (2019) Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study. Mult Scler Relat Dis 35: 262-269. https://doi.org/10.1016/j.msard.2019.07.029 ![]() |
[95] |
Twork S, Wiesmeth S, Spindler M, et al. (2010) Research. Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS). Health Qual Lif Outcomes 8: 55. https://doi.org/10.1186/1477-7525-8-55 ![]() |
[96] |
Dymecka J, Gerymski R, Tataruch R, et al. (2022) Sense of Coherence and Health-Related Quality of Life in Patients with Multiple Sclerosis: The Role of Physical and Neurological Disability. J Clin Med 11: 1716. https://doi.org/10.3390/jcm11061716 ![]() |
[97] |
Reguera-García MM, Liébana-Presa C, Álvarez-Barrio L, et al. (2020) Physical activity, resilience, sense of coherence and coping in people with multiple sclerosis in the situation derived from COVID-19. Int J Environ Res Public Health 17: 8202. https://doi.org/10.3390/ijerph17218202 ![]() |
[98] |
Hyphantis T, Almyroudi A, Paika V, et al. (2013) Anxiety, depression and defense mechanisms associated with treatment decisional preferences and quality of life in non-metastatic breast cancer: a 1-year prospective study. Psycho-Oncology 22: 2470-2477. https://doi.org/10.1002/pon.3308 ![]() |
[99] |
Paika V, Almyroudi A, Tomenson B, et al. (2010) Personality variables are associated with bowel cancer patients' quality of life independent of psychological distress and disease severity. Psycho-Oncology 19: 273-282. https://doi.org/10.1002/pon.1563 ![]() |
[100] |
Hyphantis T, Paika V, Almyroudi A, et al. (2011) Personality variables as predictors of colorectal cancer patients' psychological distress and health-related quality of life: a one-year prospective study. J Psychosom Res 70: 411-421. https://doi.org/10.1016/j.jpsychores.2010.09.011 ![]() |
[101] |
Goulia P, Voulgari PV, Tsifetaki N, et al. (2010) Comparison of health-related quality of life and associated psychological factors between younger and older patients with established rheumatic disorders. Aging Ment Health 14: 819-827. https://doi.org/10.1080/13607861003781809 ![]() |
[102] | Bond M (1992) An empirical study of defensive styles: The Defense Style Questionnaire. Ego mechanisms of defense: A guide for clinicians and researchers (pp. 127–158) . Washington, DC: American Psychiatric Press, Inc. |
[103] |
Drotar D (1997) Relating Parent and Family Functioning to the Psychological Adjustment of Children with Chronic Health Conditions: What Have We Learned? What Do We Need To Know?. J Pediatr Psychol 22: 149-165. https://doi.org/10.1093/jpepsy ![]() |
[104] |
Steiner H, Levine S (1988) Family environment of adolescents and coping in the hospital. Psychoneuroendocrinology 13: 333-338. https://doi.org/10.1016/0306-4530(88)90058-3 ![]() |
[105] |
Garfield AC, Lincoln NB (2012) Factors affecting anxiety in multiple sclerosis. Disabil Rehabil 34: 2047-2052. https://doi.org/10.3109/09638288.2012.667503 ![]() |
[106] |
Fruehwald S, Loeffler-Stastka H, Eher R, et al. (2001) Depression and quality of life in multiple sclerosis: Depression and QoL in MS. Acta Neurol Scand 104: 257-261. https://doi.org/10.1034/j.1600-0404.2001.00022.x ![]() |
[107] |
Boeschoten RE, Braamse AMJ, Beekman ATF, et al. (2017) Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. J Neurol Sci 372: 331-341. https://doi.org/10.1016/j.jns.2016.11.067 ![]() |
[108] | Salehpoor G, Rezaei S, Hosseininezhad M (2014) Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran. Iran J Nurs Midwifery Res 19: 593-599. |
[109] |
Szilasiova J, Krokavcova M, Gdovinova Z, et al. (2011) Quality of life in patients with multiple sclerosis in Eastern Slovakia. Disabil Rehabil 33: 1587-1593. https://doi.org/10.3109/09638288.2010.540292 ![]() |
[110] |
Santos M, Sousa C, Pereira M, et al. (2019) Quality of life in patients with multiple sclerosis: A study with patients and caregivers. Dis Health J 12: 628-634. https://doi.org/10.1016/j.dhjo.2019.03.007 ![]() |
[111] |
Sesel AL, Sharpe L, Naismith SL (2018) Efficacy of psychosocial interventions for people with multiple sclerosis: A meta-analysis of specific treatment effects. Psychother Psychosom 87: 105-111. https://doi.org/10.1159/000486806 ![]() |
1. | D E Andreev, P V Baranov, A Milogorodskii, D Rachinskii, A deterministic model for non-monotone relationship between translation of upstream and downstream open reading frames, 2021, 38, 1477-8599, 490, 10.1093/imammb/dqab015 | |
2. | Aleksandra V. Suhorukova, Denis S. Sobolev, Irina G. Milovskaya, Vitaliy S. Fadeev, Irina V. Goldenkova-Pavlova, Alexander A. Tyurin, A Molecular Orchestration of Plant Translation under Abiotic Stress, 2023, 12, 2073-4409, 2445, 10.3390/cells12202445 | |
3. | Arash Tirandaz, Abolfazl Ramezanpour, Vivi Rottschäfer, Mehrad Babaei, Andrei Zinovyev, Alireza Mashaghi, Messenger size optimality in cellular communications, 2025, 111, 2470-0045, 10.1103/PhysRevE.111.044406 |
Parameter | Model(s) | Parameter meaning in a specific model and relation to other parameters |
kT | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of transcription process |
k1 | M 0, M 0', M 0'reg | Rate constant of translation initiation. It includes the 40S subunit binding and scanning for the start codon. In the simplest model M 0 it denotes both the rate of the first round of initiation and all further initiation events on already translated mRNA. |
k2 | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of ribosome assembly, including possible transient arrest of ribosomes before starting translation. |
k3 | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of translation elongation step; it also includes the rate of translation termination |
kd | M 0, M 0', M 1, M 0'reg | Rate constant of mRNA degradation |
krd | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of premature ribosomal drop-off from translated mRNA |
kp | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of protein degradation |
k01 | M 0', M 0'reg | Rate constant of the first round mRNA initialization and binding of the 40S subunit including specific steps of initialization |
k02 | M 0', M 1' | Rate constant of the first round of ribosomal assembly on initiated mRNA |
k+1, k−1 | M 1, M 1' | Rate constants of reversible binding of 40S subunit to mRNA |
ka | M 1, M 1' | Rate constant of 40S subunit scanning of 5'UTR for the start codon. In the model M 1' it includes binding of factors facilitating the scanning, collectively denoted as IF2 |
k+01, k−01 | M 1' | Rate constants of reversible binding of both translation initiation factors, collectively denoted as IF1 and 40S to the naked mRNA (first round of initialisation) |
k b | M 0'reg | Rate constant of irreversible binding of a regulatory molecule (such as microRNA) to mRNA |
k+s, k−s | M 0'reg | Rate constant of reversible capturing of mRNA to a compartment (such as P-bodies) where the translation is inhibited |
kbd | M 0'reg | Rate constant of degradation of mRNA in a compartment where the translation is inhibited |
Parameter | Model(s) | Parameter meaning in a specific model and relation to other parameters |
kT | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of transcription process |
k1 | M 0, M 0', M 0'reg | Rate constant of translation initiation. It includes the 40S subunit binding and scanning for the start codon. In the simplest model M 0 it denotes both the rate of the first round of initiation and all further initiation events on already translated mRNA. |
k2 | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of ribosome assembly, including possible transient arrest of ribosomes before starting translation. |
k3 | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of translation elongation step; it also includes the rate of translation termination |
kd | M 0, M 0', M 1, M 0'reg | Rate constant of mRNA degradation |
krd | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of premature ribosomal drop-off from translated mRNA |
kp | M 0, M 0', M 1, M 1', M 0'reg | Rate constant of protein degradation |
k01 | M 0', M 0'reg | Rate constant of the first round mRNA initialization and binding of the 40S subunit including specific steps of initialization |
k02 | M 0', M 1' | Rate constant of the first round of ribosomal assembly on initiated mRNA |
k+1, k−1 | M 1, M 1' | Rate constants of reversible binding of 40S subunit to mRNA |
ka | M 1, M 1' | Rate constant of 40S subunit scanning of 5'UTR for the start codon. In the model M 1' it includes binding of factors facilitating the scanning, collectively denoted as IF2 |
k+01, k−01 | M 1' | Rate constants of reversible binding of both translation initiation factors, collectively denoted as IF1 and 40S to the naked mRNA (first round of initialisation) |
k b | M 0'reg | Rate constant of irreversible binding of a regulatory molecule (such as microRNA) to mRNA |
k+s, k−s | M 0'reg | Rate constant of reversible capturing of mRNA to a compartment (such as P-bodies) where the translation is inhibited |
kbd | M 0'reg | Rate constant of degradation of mRNA in a compartment where the translation is inhibited |